ALLISON HAWKINS: Open Payments
NPI 1477804649 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,912 in 127 payments from 34 companies in 2025. Trend: 2023 $2,084 · 2024 $1,830 · 2025 $2,912
Food & beverage: $2,912
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $405 |
| Janssen Biotech, Inc. | 15 | $249 |
| Novartis Pharmaceuticals Corporation | 12 | $206 |
| Merck Sharp & Dohme LLC | 6 | $176 |
| Daiichi Sankyo Inc. | 8 | $167 |
| Geron Corporation | 2 | $159 |
| GENZYME CORPORATION | 6 | $157 |
| Astellas Pharma US Inc | 6 | $118 |
| Celgene Corporation | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
Products named: Enhertu, RYTELO, KEYTRUDA, RYBREVANT, IMFINZI, WAYRILZ, OPDIVO, REBLOZYL.
Industry payments across FL — which companies pay providers there.
